87,500 Shares in Avantor, Inc. $AVTR Purchased by EFG International AG

EFG International AG bought a new position in shares of Avantor, Inc. (NYSE:AVTR) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 87,500 shares of the company’s stock, valued at approximately $866,000.

A number of other hedge funds also recently added to or reduced their stakes in AVTR. Private Management Group Inc. grew its holdings in Avantor by 50.4% in the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock valued at $28,156,000 after purchasing an additional 823,572 shares during the last quarter. GSA Capital Partners LLP purchased a new position in shares of Avantor in the second quarter valued at $800,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Avantor during the 2nd quarter worth $805,000. Assenagon Asset Management S.A. raised its stake in shares of Avantor by 425.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock worth $5,513,000 after buying an additional 450,801 shares during the last quarter. Finally, Brickwood Asset Management LLP boosted its position in shares of Avantor by 6,891.9% in the 4th quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock worth $36,489,000 after buying an additional 3,138,504 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AVTR has been the topic of a number of research reports. Barclays increased their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, June 24th. Sanford C. Bernstein began coverage on shares of Avantor in a report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target on the stock. Citigroup upped their price target on shares of Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Wells Fargo & Company raised their price objective on shares of Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Avantor has an average rating of “Hold” and a consensus price target of $12.00.

Avantor Price Performance

AVTR stock opened at $14.59 on Friday. Avantor, Inc. has a 52-week low of $7.26 and a 52-week high of $15.93. The stock’s fifty day simple moving average is $12.02 and its 200-day simple moving average is $9.74. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $9.87 billion, a price-to-earnings ratio of -17.37, a price-to-earnings-growth ratio of 10.94 and a beta of 0.89.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the prior year, the firm posted $0.24 earnings per share. The business’s quarterly revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts expect that Avantor, Inc. will post 0.81 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.